Search

Search Constraints

You searched for: Author/Creator Gaia, S.

Search Results

2. Is stiffness reliable for the detection of liver fibrosis in HCV patients treated with direct acting antiviral drugs (DAAs)? A prospective cohort study. Issue 1 (February 2018)

3. Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes. (March 2023)

4. OC.05.4 Y90-RADIOEMBOLIZATION VERSUS SORAFENIB IN LOCALLY ADVANCED HCC WITH INTRAHEPATIC NEOPLASTIC PORTAL VEIN THROMBOSIS: THE PIEDMONT-AOSTA VALLEY ONCOLOGY NETWORK EXPERIENCE. (1st October 2020)

5. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes a pro-tumorigenic inflammatory response. (March 2023)

7. PD-0915 SABR as a bridge therapy for HCC patients awaiting liver transplant. (August 2021)

9. Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3). (February 2020)